The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Solaraze 3% gel



Lexon Pharmaceuticals (Ireland) LimitedPPA23176/021/001

Main Information

Trade NameSolaraze 3% gel
Active SubstancesDiclofenac sodium
Dosage FormGel
Licence HolderLexon Pharmaceuticals (Ireland) Limited
Licence NumberPPA23176/021/001

Group Information

ATC CodeD11AX18 diclofenac

Status

License statusAuthorised
Licence Issued06/07/2018
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListDiclofenac Sodium 3% w/w Gel
Interchangeable List CodeIC0056-123-043
Interchangeable List DocumentPDF of Interchangeable List
« Back